Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA‐30d in patient with prostate cancer
- 24 May 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (9) , 7245-7255
Abstract
AT‐rich interaction domain 4A (ARID4A) and AT‐rich interaction domain 4B (ARID4B), which are both the AT‐rich interaction domain (ARID) family, have been reported to be oncogene or tumor suppressor gene in various human malignances, but there is no involvement about their functions in prostate cancer (PCa). Our previous study has reported that microRNA‐30d (miR‐30d) expression can predicted poor clinical prognosis in PCa, however, the underlying mechanisms of miR‐30d have not been fully described. The aim of our study is to investigate the expression relevance between miR‐30d and ARID4A or ARID4B, and examine the clinical significance and biological function of ARID4A and AIRD4B in PCa. In this study, both ARID4A and ARID4B were identified as the target genes of miR‐30d. In addition, the mRNA expression of miR‐30d in PCa tissues were significantly negative correlated with ARID4A (Pearson correlation coefficient = −0.313, P = 0.001) and ARID4B (Pearson correlation coefficient = −0.349, P < 0.001), while there was a positive correlation between ARID4A and ARID4B (Pearson correlation coefficient = 0.865, P < 0.001). Moreover, both ARID4A and ARID4B were significantly downregulated in PCa tissues with high Gleason scores (P = 0.005, P = 0.033), PSA failure (P = 0.012, P = 0.05) and short biochemical recurrent‐free survival (P = 0.033, P = 0.031). Furthermore, the knockout expression of ARID4A and ARID4B promoted PCa cell proliferation, migration and invasion in vitro. In conclusion, our results indicated that ARID4A and ARID4B may serve as tumor suppressor in PCa progression, suggesting that they might be the potential therapeutic targets in prostate cancer.Keywords
Funding Information
- National Natural Science Foundation of China (81470983, 81571427, 81600620, 81641102)
This publication has 30 references indexed in Scilit:
- Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patientsBMC Genomics, 2013
- BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancerJournal of Nanobiotechnology, 2011
- The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progressionJournal of Clinical Investigation, 2010
- Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sitesGenome Biology, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Genetic variation in microRNA networks: the implications for cancer researchNature Reviews Cancer, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Identification of Chromatin Remodeling Genes Arid4a and Arid4b as Leukemia Suppressor GenesJNCI: Journal of the National Cancer Institute, 2008
- Alterations of BRMS1-ARID4A Interaction Modify Gene Expression but Still Suppress Metastasis in Human Breast Cancer CellsJournal of Biological Chemistry, 2008
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005